{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:54:56Z","timestamp":1792792496435,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["G-2106-04697"],"award-info":[{"award-number":["G-2106-04697"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Study of Inflammatory Bowel Disease"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162393"],"award-info":[{"award-number":["PJT-162393"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary sclerosing cholangitis is a chronic liver disease associated with significant morbidity, mortality, and healthcare utilization. We conducted a systematic review and meta-analysis of population-based studies of the incidence and prevalence of primary sclerosing cholangitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline and Embase were systematically searched to identify population-based studies of a defined geographic area and reported the incidence or prevalence of primary sclerosing cholangitis in the general population. Meta-analyses, using random-effects, were performed to calculate overall and country-specific incidence (per 100 000 persons\/year) and prevalence rates (per 100 000 persons) with 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 14 studies on incidence and the 12 for prevalence originated from North America, Asia, Europe, and Oceania. Incidence and prevalence rates of primary sclerosing cholangitis were 0.87 (95% confidence interval, 0.59-1.29) and 13.53 (95% confidence interval, 10.20-17.94) per 100 000 persons, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both the prevalence and incidence of primary sclerosing cholangitis is low in the general population. Future studies on the incidence and prevalence of primary sclerosing cholangitis in the general population should be directed at Asia, Africa, and Latin America to allow for a more robust assessment of the global epidemiology of primary sclerosing cholangitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izad276","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T17:00:15Z","timestamp":1699894815000},"page":"2019-2026","source":"Crossref","is-referenced-by-count":44,"title":["Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies"],"prefix":"10.1093","volume":"30","author":[{"given":"Jared","family":"Cooper","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]},{"name":"Division of Gastroenterology, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Markovinovic","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-7226","authenticated-orcid":false,"given":"Stephanie","family":"Coward","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Herauf","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz","family":"Shaheen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Swain","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-940X","authenticated-orcid":false,"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-9948","authenticated-orcid":false,"given":"Christopher","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-7048","authenticated-orcid":false,"given":"Cathy","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Novak","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen I","family":"Kroeker","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew C","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, LKS Institute of Digestive Disease, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong , Hong Kong ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0556","authenticated-orcid":false,"given":"Gilaad G","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"10139","key":"2024110408175056800_CIT0001","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet."},{"issue":"5","key":"2024110408175056800_CIT0002","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"2024110408175056800_CIT0003","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology."},{"issue":"6","key":"2024110408175056800_CIT0004","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology."},{"issue":"10","key":"2024110408175056800_CIT0005","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15007","article-title":"Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"41","author":"Mehta","year":"2021","journal-title":"Liver international"},{"issue":"1","key":"2024110408175056800_CIT0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.epirev.a017974","article-title":"Population-based Cohort Studies","volume":"20","author":"Szklo","year":"1998","journal-title":"Epidemiol Rev."},{"key":"2024110408175056800_CIT0007","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"PG. Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Egger","year":"2001","edition":"2"},{"key":"2024110408175056800_CIT0008","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"2024110408175056800_CIT0009","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"5","key":"2024110408175056800_CIT0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"2024110408175056800_CIT0011","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology."},{"issue":"5","key":"2024110408175056800_CIT0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","article-title":"An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort","volume":"55","author":"Bakhshi","year":"2020","journal-title":"J Gastroenterol."},{"issue":"1","key":"2024110408175056800_CIT0013","first-page":"132","article-title":"P32 evaluating the natural history of primary sclerosing cholangitis (PSC): a Canadian population-based study","volume":"6","author":"Patel","year":"2023","journal-title":"Canadian Liver Journal"},{"issue":"1","key":"2024110408175056800_CIT0014","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol."},{"issue":"1","key":"2024110408175056800_CIT0015","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2020","journal-title":"JHEP Rep"},{"issue":"09","key":"2024110408175056800_CIT0016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.17992\/lbl.2019.09.245","article-title":"Primary sclerosing cholangitis in Iceland 1992-2012","volume":"2019","author":"Gu\u00f0nason","year":"2019","journal-title":"L\u00e6knabla\u00f0i\u00f0."},{"issue":"9","key":"2024110408175056800_CIT0017","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/ijerph17093095","article-title":"Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy","volume":"17","author":"Carbone","year":"2020","journal-title":"Int J Environ Res Public Health."},{"issue":"6","key":"2024110408175056800_CIT0018","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology."},{"issue":"1","key":"2024110408175056800_CIT0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J of Gastroenterol."},{"issue":"2","key":"2024110408175056800_CIT0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology."},{"issue":"7","key":"2024110408175056800_CIT0021","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology."},{"issue":"1","key":"2024110408175056800_CIT0022","doi-asserted-by":"crossref","first-page":"2221368","DOI":"10.1080\/22423982.2023.2221368","article-title":"A nationwide study of autoimmune liver diseases in the Faroe Islands: incidence, prevalence, and causes of death 2004-2021","volume":"82","author":"Nielsen","year":"2023","journal-title":"Int J Circumpolar Health."},{"issue":"12","key":"2024110408175056800_CIT0023","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2024110408175056800_CIT0024","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"2024110408175056800_CIT0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology."},{"issue":"10114","key":"2024110408175056800_CIT0026","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"issue":"5","key":"2024110408175056800_CIT0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","article-title":"Past and future burden of inflammatory bowel diseases based on modeling of population-based data","volume":"156","author":"Coward","year":"2019","journal-title":"Gastroenterology."},{"issue":"1","key":"2024110408175056800_CIT0028","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"5","key":"2024110408175056800_CIT0029","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"1","key":"2024110408175056800_CIT0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cgh.2019.05.013","article-title":"Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases","volume":"18","author":"Lynch","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2024110408175056800_CIT0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: A critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J Autoimmun."},{"issue":"8","key":"2024110408175056800_CIT0032","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J Gastroenterol Hepatol."},{"issue":"8","key":"2024110408175056800_CIT0033","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"2024110408175056800_CIT0034","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol."},{"issue":"9","key":"2024110408175056800_CIT0035","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad276\/54025632\/izad276.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/11\/2019\/59882117\/izad276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/11\/2019\/59882117\/izad276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T03:18:14Z","timestamp":1730690294000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/11\/2019\/7459309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,12,5]]},"published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad276","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2023,12,5]]}}}